ATLANTA, April 24, 2023 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (VIRI) (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company focused on advancing novel, combination antiviral ...
-Company will Provide Material Updates on Further FDA Guidance as Process Proceeds for This Important FDA “Fast-track” Designated Program- There is significant unmet medical need in the FM patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results